Genome wide analysis points towards subtype-specific diseases in different genetic forms of amyotrophic lateral sclerosis

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung



Amyotropic lateral sclerosis (ALS) is a lethally progressive and irreversible neurodegenerative disease marked by apparent death of motor neurons present in the spinal cord, brain stem and motor cortex. While more and more gene mutants being established for genetic ALS, the vast majority suffer from sporadic ALS (>90%). It has been challenging, thus, to model sporadic ALS which is one reason why the underlying pathophysiology remains elusive and has stalled the development of therapeutic strategies of this progressive motor neuron disease. To further unravel these pathological signaling pathways, human induced pluripotent stem cell (hiPSCs)-derived motor neurons (MNs) from FUS-and SOD1 ALS patients and healthy controls were systematically compared to independent published datasets. Here through this study we created a gene profile of ALS by analyzing the DEGs, the Kyoto encyclopedia of Genes and Genomes (KEGG) pathways, the interactome and the transcription factor profiles (TF) that would identify altered molecular/functional signatures and their interactions at both transcriptional (mRNAs) and translational levels (hub proteins and TFs). Our findings suggest that FUS and SOD1 may develop from dysregulation in several unique pathways and herpes simplex virus (HSV) infection was among the topmost predominant cellular pathways connected to FUS and not to SOD1. In contrast, SOD1 is mainly characterized by alterations in the metabolic pathways and alterations in the neuroactive-ligand–receptor interactions. This suggests that different genetic ALS forms are singular diseases rather than part of a common spectrum. This is important for patient stratification clearly pointing towards the need for individualized medicine approaches in ALS.


FachzeitschriftInternational journal of molecular sciences
PublikationsstatusVeröffentlicht - 2 Sept. 2020

Externe IDs

PubMed 32967368
ORCID /0000-0002-7688-3124/work/142250016


Ziele für nachhaltige Entwicklung


  • Amyotrophic lateral sclerosis (ALS), Differentially expressed genes (DEGs), Human induced pluripotent stem cells (iPSC), Kyoto encyclopedia of Genes and Genomes (KEGG), Motorneurons (MN)